- Keywords > Global Fund for Tuberculosis, Aids and Malaria
- Keywords > HIV/AIDS Medical Supplies and Laboratory Commodities
- Keywords > needs assessment
- Keywords > pharmaceutical management - antiretroviral medicines (ARV)
- Keywords > procurement and supply management (PSM)
- Keywords > quantification - forecasting of medicines and supplies
- Keywords > quantification - needs for HIV and AIDS commodities
- Keywords > quantification of commodities
(2013; 25 pages)
Kane, A., N. Amanye Botiba, E. Ngemne, and F. Munyaburanga. 2014. Report on Quantification of Needs for HIV and AIDS Commodities and the Revised PSM Plan for the CTG/NACC under the Global Fund’s New Funding Model in Cameroon. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.
In Cameroon, the needs for antiretrovirals (ARVs) and other HIV commodities on a national scale have increased significantly over the years with the increase in the number of HIV-positive people registering for treatment.
Financial partners such as the World Bank, the French Development Agency (Agence Française de Développement; AFD), and PEPFAR have committed their support alongside technical partners—the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program implemented by Management Sciences for Health, the Clinton Health Access Initiative (CHAI), the US Centers for Disease Control and Prevention (CDC), the United Nations Children’s Fund (UNICEF), the ESTHERAID Project (Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau contre le SIDA), and others—to make HIV commodities available.
All of this funding has made it possible to quantify needs in commodities. This paper describes the quantification exercise done to meet the following objectives:
- quantify needs for the new funding model;
- quantify needs for the remainder of Phase 1, Round 10 of the Global Fund;
- plan commodity shipments; and
- revise the Pharmaceutical Supply Management Plan.